source
- AstraZeneca hints restructuring may trim R&D budget and move trials to emerging marketsAstraZeneca's chief executive Pascal Soriot told journalists that the company's new restructuring program could lead to cost reductions in research and development and may see some clinical trials…
- Podcast examines Merck and Moderna’s mRNA cancer vaccine data presented at ESMOThe latest episode of STAT’s biotech podcast "The Readout LOUD" focused on the mRNA cancer vaccine being co‑developed by Merck and Moderna, using data shown at the European Society for Medical Onco…